iSpecimen Inc. (Nasdaq:ISPC)
N/A • N/A
CIK 1558569
Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
Address
8 Cabot Road
Suite 1800
Woburn, Massachusetts 01801
8 Cabot Road
Suite 1800
Woburn, Massachusetts 01801
Employees
53
53
Stock Info
Close
$1.4800
$1.4800
Day Range
1.4382 - 1.5600
1.4382 - 1.5600
52 Week Range
1.2950 - 11.8000
1.2950 - 11.8000
Average volume
888.18K
888.18K
Short Interest
29.56K (02/14/25)
29.56K (02/14/25)
% of Float Shorted
3.59%
3.59%
Market Cap
$1.42M
$1.42M
Revenue
$9.93M
$9.93M
Net Income
-$11.1M
-$11.1M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
CEO, Secretary, Treasurer & Director Robert Bradley Lim |
Chairman Richard Joel Paolone |
President Katharyn M. Field |
Independent Director Siyun Yang |
Independent Director Avtar S. Dhaliwal |
Independent Director John L. Brooks III |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | 8-K | |
13 Dec, 2024 | 8-K | |
13 Dec, 2024 | 3 | |
12 Dec, 2024 | 8-K | |
12 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
31 Oct, 2024 | 8-K | |
31 Oct, 2024 | 424B4 | |
29 Oct, 2024 | EFFECT | |
28 Oct, 2024 | CORRESP | |
28 Oct, 2024 | CORRESP | |
24 Oct, 2024 | UPLOAD | |
18 Oct, 2024 | S-1 | |
2 Oct, 2024 | 8-K | |
30 Sep, 2024 | 3 | |
30 Sep, 2024 | 4 | |
27 Sep, 2024 | 4 | |
27 Sep, 2024 | 4 | |
27 Sep, 2024 | 3 | |
27 Sep, 2024 | 3 | |
25 Sep, 2024 | 8-K | |
11 Sep, 2024 | 8-K | |
6 Aug, 2024 | 10-Q | |
6 Aug, 2024 | 8-K | |
22 Jul, 2024 | 8-K | |
9 Jul, 2024 | SCHEDULE 1 | |
8 Jul, 2024 | 8-K | |
3 Jul, 2024 | 8-K | |
10 Jun, 2024 | DEF 14A | |
10 Jun, 2024 | ARS | |
28 May, 2024 | PRER14A | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
17 May, 2024 | 8-K | |
7 May, 2024 | 10-Q | |
7 May, 2024 | 8-K | |
11 Apr, 2024 | 8-K | |
28 Mar, 2024 | PRE 14A | |
26 Mar, 2024 | 8-K | |
26 Mar, 2024 | 3 | |
14 Mar, 2024 | 8-K | |
13 Mar, 2024 | 10-K | |
5 Mar, 2024 | 8-K | |
5 Mar, 2024 | 424B5 | |
15 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
8 Feb, 2024 | 5 | |
21 Dec, 2023 | 8-K | |
2 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 8-K | |
23 Oct, 2023 | 8-K | |
10 Oct, 2023 | 8-K | |
15 Sep, 2023 | 4 | |
6 Sep, 2023 | 8-K | |
2 Aug, 2023 | 8-K | |
2 Aug, 2023 | 10-Q | |
7 Jul, 2023 | 8-K | |
1 Jun, 2023 | 4 | |
25 May, 2023 | 8-K | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
4 May, 2023 | 10-Q | |
4 May, 2023 | 8-K | |
17 Apr, 2023 | SC 13D | |
10 Apr, 2023 | ARS | |
10 Apr, 2023 | DEF 14A | |
10 Apr, 2023 | DEFA14A | |
31 Mar, 2023 | 8-K | |
31 Mar, 2023 | PRE 14A | |
30 Mar, 2023 | 10-K/A | |
21 Mar, 2023 | 10-K | |
14 Mar, 2023 | 8-K | |
13 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
19 Jan, 2023 | 4 | |
19 Jan, 2023 | 4 | |
19 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
12 Jan, 2023 | SC 13G/A | |
10 Jan, 2023 | 8-K | CEO Change |
30 Dec, 2022 | 424B3 | |
27 Dec, 2022 | SC 13G/A | |
1 Dec, 2022 | 3 | |
28 Nov, 2022 | 8-K | |
14 Nov, 2022 | 4 | |
10 Nov, 2022 | 4 | |
8 Nov, 2022 | 8-K | |
8 Nov, 2022 | 10-Q | |
4 Nov, 2022 | 4 | |
4 Nov, 2022 | 4 | |
28 Oct, 2022 | 8-K | |
28 Sep, 2022 | SC 13G | |
22 Sep, 2022 | 8-K | CEO Change |
5 Aug, 2022 | EFFECT | |
5 Aug, 2022 | 424B3 | |
4 Aug, 2022 | 8-K | |
4 Aug, 2022 | 10-Q | |
3 Aug, 2022 | UPLOAD | |
3 Aug, 2022 | CORRESP | |
29 Jul, 2022 | S-3 | |
12 Jul, 2022 | EFFECT | |
8 Jul, 2022 | UPLOAD | |
8 Jul, 2022 | CORRESP | |
1 Jul, 2022 | S-3 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
21 Jun, 2022 | 8-K | |
7 Jun, 2022 | 424B3 | |
6 Jun, 2022 | EFFECT | |
26 May, 2022 | 8-K | |
26 May, 2022 | POS AM | |
10 May, 2022 | 10-Q | |
10 May, 2022 | 8-K | |
29 Apr, 2022 | 8-K | |
14 Apr, 2022 | DEF 14A | |
14 Apr, 2022 | DEFA14A | |
30 Mar, 2022 | PRE 14A | |
22 Mar, 2022 | 10-K | |
7 Mar, 2022 | 8-K | |
24 Feb, 2022 | 4 | |
23 Feb, 2022 | 4 | |
17 Feb, 2022 | 8-K | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
7 Feb, 2022 | SC 13G | |
24 Jan, 2022 | SC 13G | |
10 Jan, 2022 | 8-K | |
23 Dec, 2021 | 424B3 | |
23 Dec, 2021 | EFFECT | |
21 Dec, 2021 | UPLOAD | |
21 Dec, 2021 | CORRESP | |
16 Dec, 2021 | S-8 | |
14 Dec, 2021 | S-1 | |
9 Dec, 2021 | D | |
2 Dec, 2021 | 8-K | |
29 Nov, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
17 Nov, 2021 | 4 | |
4 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | |
16 Aug, 2021 | 8-K | |
10 Aug, 2021 | 8-K | |
10 Aug, 2021 | 10-Q | |
9 Jul, 2021 | SC 13G | |
1 Jul, 2021 | 8-K | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
22 Jun, 2021 | 8-K | |
18 Jun, 2021 | 424B4 | IPO completed |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | EFFECT | |
16 Jun, 2021 | CERT | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
14 Jun, 2021 | 8-A12B | |
14 Jun, 2021 | CORRESP | |
14 Jun, 2021 | CORRESP | |
28 May, 2021 | FWP | |
27 May, 2021 | S-1/A | |
13 May, 2021 | S-1/A | |
27 Apr, 2021 | CORRESP | |
27 Apr, 2021 | S-1/A | |
26 Apr, 2021 | UPLOAD | |
2 Apr, 2021 | CORRESP | |
2 Apr, 2021 | S-1/A | |
1 Feb, 2021 | UPLOAD | |
20 Jan, 2021 | S-1/A | |
20 Jan, 2021 | CORRESP | |
15 Jan, 2021 | UPLOAD | |
31 Dec, 2020 | CORRESP | |
14 Dec, 2020 | UPLOAD |
Last update:2025-03-06 13:20:05.339067
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.